Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. [electronic resource]
Producer: 20121018Description: 683-8 p. digitalISSN:- 1879-1913
- Aged
- Biomarkers -- blood
- Cardiac Resynchronization Therapy -- methods
- Case-Control Studies
- Confidence Intervals
- Defibrillators, Implantable
- Diabetes Mellitus, Type 2 -- blood
- Disease Progression
- Disease-Free Survival
- Echocardiography, Doppler -- methods
- Female
- Follow-Up Studies
- Glycated Hemoglobin -- metabolism
- Heart Failure, Systolic -- complications
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Multivariate Analysis
- Predictive Value of Tests
- Retrospective Studies
- Risk Assessment
- Severity of Illness Index
- Statistics, Nonparametric
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.